All News

Listen to part I of our #ACR20 Day 3 recap. Follow the link below or find us on Apple podcasts. https://t.co/STTgimaUjp https://t.co/Zh2wZRnbyS

Links:

Dr. John Cush RheumNow ( View Tweet)
Retrosp study in France compared MRIs of 96 pts w/ SpA (65% w/ IBP) vs 104 w/o (25% w/ IBP): - 65% of pts w/ SpA had bone marrow edema (BME) mainly in the iliac quad of intermed middle segment - 20% w/o SpA had BME mainly in antero-middle quad. #Abst1535 #ACR2020 @RheumNow https://t.co/1ptGGUbUS4
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
~1/3 early RA patients report unacceptable pain w/in one year of diagnosis. 69% have pain w/ low inflammation. No objective baseline measures predict unacceptable pain. #ACR20 @RheumNow Abs#1716 We need to start pain approaches at time of diagnosis for all

Eric Dein ejdein1 ( View Tweet)

#AerobicExercise improves #Fatigue & #QualityofLife in women w/ #SLE - ↓Fatigue & ↑overall health after exercise program - No increase in #lupus activity - Data may inform understanding of fatigue & exercise interventions in SLE Abs#1838 #ACR20 @RheumNow https://t.co/0YtYHrWp6t

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

How often do you perform NFC in suspected SSc patients? @RheumNow #ACR20

sheila RHEUMarampa ( View Tweet)

@uptoTate @RheumNow It is only when I started working more closely with our rheum team to look at improving services did I realise how high no-shows are ! We have a 2yr waiting list so these appts are like gold dust. Unfortunately telemedicine not a viable option for your 1st rheum appt.

Wendy Costello wendycostello2 ( View Tweet)

Pulmonary disease and glucocorticoid usage risk factors for RA medication changes in first 3 month of #COVID19. Pts with higher reported disease activity more likely to make Rx changes #ACR20 @RheumNow. Abst#L05.

Eric Dein ejdein1 ( View Tweet)

No need to stop Tofa w/the flu? 👉Posthoc analysis 7964 Tofa pts over 14-15 flu seasons reported similar flu rates compared to ADA, MTX, PCB. 👉Tofa cont. in 70% pts; 28.8% stopped; mean days to resolution similar. Abstr#L04 #ACR20 @rheumnow #ACRBest https://t.co/rZXKRVl7uK

Links:

k dao KDAO2011 ( View Tweet)

Frequency and Anatomic Distribution of MRI Lesions in the Sacroiliac Joints of Healthy Subjects and Patients with Spondyloarthritis. Dr Hecquet. #ACR20 @RheumNow BME was seen in 65% patients with Spa and in 20% without spondyloarthritis predominantly in the antero-middle quadrant https://t.co/OUYz2FQ5Yp
Sole RetamozoSole ( View Tweet)
Accdg to this study, no association was found between IFN levels and cognitive function in SLE pts (even after considering factors like SLE dse duration) Interesting! @RheumNow #ACR20 abs1788 @ZahiTouma https://t.co/F4j8H1CWJ9
sheila RHEUMarampa ( View Tweet)
Important work by Dr. Winthrop on influenza AEs in Tofacinitib patients - similar among 5mg/10mg BID, only 2 deaths/~500 cases, both with H1N1 and co-morbid RFs. Abst#L04 @RheumNow #ACR20 https://t.co/7MZYGv8W3i
Eric Dein ejdein1 ( View Tweet)
Do you have a problem with no-shows? #ABS1584 discusses telemedicine and care access during COVID-19. Case Western observed a 0% cancellation rate, <10% no-show rate, & 90% of scheduled telemed visits completed during COVID-19. #ACR20 #ACRbest @RheumNow https://t.co/uxzpfELDBG https://t.co/U2qrOTJZOq

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
My axSpA patients often ask me whether whether it's the weight loss that matters, or just exercise. Some answers from @rheum_cat - BMI itself does matter in AS. Another one chalked up for the obesity-related inflammasome! #ACR20 ABST1883 @RheumNow https://t.co/oMOqA8ypTt
David Liew drdavidliew ( View Tweet)
Encouraging results on selective TK2 inhibitor in active PsA patients. ACR20 at week 16 of 53% and 63%, for low and high dose, compared to 32% placebo. NP, sinusitis, ha, rash most common AEs. Abst#L03 @RheumNow #ACR20 https://t.co/2UrOKFfnCL
Eric Dein ejdein1 ( View Tweet)
Evidence that patients on biologics getting COVID less frequently should be interpreted with the knowledge that Abst#L02 shows increased shielding/risk mitigation of patients on biologics #ACR20 @RheumNow https://t.co/Dn1lUtd6hl
Eric Dein ejdein1 ( View Tweet)

Abst#L01. Pt is on MTX/ADA for RA and asks you about their COVID risk. What do you counsel your patient? #ACR20 @RheumNow.

Eric Dein ejdein1 ( View Tweet)

What are you telling rheum pts their risk is for COVID? MGH: higher unadjusted rate of mech ventilation, but not signif difference after adj for co-morbidities. Encouraging temporal improvement in care seen. Abst#L01 #ACR20 @Rheumnow https://t.co/BnPCtbo5Nj
Eric Dein ejdein1 ( View Tweet)
Poster #L02 by @yatesmark1 et al shows #shielding in #IMID population on biologics may at least in part explain the lower risk of adverse #COVID19 outcomes in this group. Reinforces need for clear guidance on risk mitigation for patients. #ACR20 @RheumNow https://t.co/H4RMbfBrH2

Links:

Mrinalini Dey DrMiniDey ( View Tweet)

Fatigue in RA - massive burden on patients. Intensity of fatigue in RA is a/w: pain, psychological distress, morning stiffness but not a/w: ESR, CRP, swollen joint count Fatigue needs its own consideration, separate to RA 'dx activity'! ESPOIR cohort #ACR20 ABST1727 @RheumNow https://t.co/Uqu5LDvSV6
David Liew drdavidliew ( View Tweet)
Early RA window of opportunity: how hard, how early? Commonsense reassurance from ESPOIR: to get good outcomes at 10y (DAS28≤2.6, HAQ≤0.5): - csDMARD early - bDMARD second line is okay, within first 1y+ (analysis weighted for subsequent Rx exposure) #ACR20 ABST1717 @RheumNow https://t.co/kG9WYUYYef
David Liew drdavidliew ( View Tweet)
×